AI assistant
Precise Biometrics Interim / Quarterly Report 2010
3189_10-q_2020-09-11_543ccf5e-4f5b-4365-a1c3-675487cc2c64.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
PRECISE™ BIOMETRICS
Page 1 of 14
Lund, April 21, 2010
STRONG GROWTH IN THE FIRST QUARTER
Precise Biometrics AB (publ), Corporate Identity No. 556545-6596
Interim Report for the period January – March 2010
- The group's net sales for the first quarter amounted to SEK 19.3 million (12.2).
- Losses for the first quarter were SEK -0.3 million (-2.6).
- Losses per share for the first quarter amounted to SEK 0.00 (-0.03).
- Liquid assets at the end of the quarter amounted to SEK 35.5 million (4.4).
Important event during the quarter
- Precise Biometrics has received an order for hardware worth SEK 4.3 million in a Match-on-Card project for government employees. The order is an additional follow-up order from an existing customer in the Middle East.
For further information
Thomas Marschall, President and CEO, Precise Biometrics AB
Tel. +46 (0)46 31 11 10 or +46 (0)734 35 11 10
E-mail [email protected]
Patrik Norberg, CFO, Precise Biometrics AB
Tel. +46 46 31 11 47 or +46 734 35 11 47
E-mail [email protected]
Precise Biometrics is a market-leading provider of products and solutions for fingerprint recognition. The technology proves people's identities in a fast and secure way, while it reduces costs related to password management, identity theft and fraud.
Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 100 million users. Precise Biometrics is listed on NASDAQ OMX Stockholm small cap list (PREC). For more information, please visit www.precisebiometrics.com.
PRECISE™ BIOMETRICS
Page 2 of 14
Lund, April 21, 2010
Strong growth in the first quarter
- Interview with the President & CEO, Thomas Marschall
How would you sum up the first quarter of 2010?
The first quarter this year saw an almost 60 per cent improvement in relation to sales, compared with the same period last year, and there was a very significant improvement in result. This was achieved in spite of the fact that the Company did not receive any major individual orders during the quarter. The main part of sales has consisted of follow-up orders for hardware to customers that have previously purchased Match-on-Card licenses.
Can you comment on the new business plan?
We will be demonstrating a continuation of our strong growth and the ambition is that within three to five years we will be a profitable company on the midcap list. We will also be focusing activities more explicitly on packaging our technology in custom-designed solutions for specific application areas. We are no longer a company primarily concerned with developing technology, we are now a company that with its unique and proved technology solves advanced problems for customers. This is essentially the main reason for the organizational change that will come into force from 1 July.
What will the new organization focus on?
We are undeniably a world leader in our industry, with almost 100 million contracted licenses for Precise Match-on-Card™. The important thing now is to build up a market-oriented organization that enables us to derive more benefit from our world-leading position, while also opening up new application areas and markets.
We will be focusing on solving problems for our customers. Precise Biometrics will also, above all in the new business areas, address end-customers directly with complete solutions and thereby become less dependent on partners. We will therefore be reinforcing the sales organization with new employees during this and the next quarter. We will also move from the present geographic segmentation and organize ourselves according to business areas.
How is the market developing?
In global terms, the market has matured and there is a considerably higher level of awareness about our technology and its advantages compared to a few years ago. We are getting more and more spontaneous inquiries and no longer need to promote the technology as much as we did before. The higher degree of maturity also means that it is somewhat easier to get an overview of the market and that there are less regional differences. This means that we can focus more on globally marketable solutions for our customers.
There has never been as much potential on the market as there is now, and we are involved in several interesting negotiations both with companies and government controlled activities. After last year's major order I still believe, for example, that it is reasonable to expect new orders from US government agencies. The greater interest being shown by corporate customers is motivated by two significant requirements: the need for cost-efficiency and to be able to compete with services that are more unique, more secure and more flexible when people need to identify themselves.
PRECISE™ BIOMETRICS
Page 3 of 14
Lund, April 21, 2010
What is your view on the Company's financial position?
We entered 2010 with a strong financial position, which in combination with ongoing orders from existing customers means that we have a good level of sustainability. Our finances also allow us to conduct offensive marketing, for example the reinforcement of our sales organization. At the same time I would like to emphasize that we will not be implementing any increases in costs that are not directly business motivated or allocated to customer assignments.
Which uncertainty factors is the Company most exposed to?
My evaluation is that the recession is no longer the uncertainty factor it has been for the last two years. We can still see some sluggishness, but the market is on the way up and there are explicit demands for our solutions. I mostly relate the uncertainty that exists to the irregular flow of earnings. We still rely on individual large orders, which cause sales to fluctuate between different quarters. Nevertheless, ongoing sales to existing customers are increasing as are earnings from licenses, which will gradually lead to a more stable level of earnings and less variation between quarters.
PRECISE™ BIOMETRICS
Page 4 of 14
Lund, April 21, 2010
Sales and result
First quarter 2010
Sales for the first quarter amounted to SEK 19.3 million (12.2). The gross margin amounted to 60%. During the corresponding period last year, with higher proportion of license sales, the gross margin amounted to 69%. The Group's net loss for the first quarter amounted to SEK -0.3 million (-2.6). Operating costs (see definition on page 9) amounted to SEK 11.7 million (10.8). Losses per share (average number of shares) for the first quarter amounted to SEK 0.00 (-0.03).
Financing and liquidity
Equity amounted as of March 31, 2010 to SEK 45.1 million (12.8) and equity/share to SEK 0.33 (0.13).
Cash flow from current operations during the quarter amounted to SEK -4.7 million (-6.5). Liquid assets as of March 31, 2010 amounted to SEK 35.5 million (4.4).
Market and sales – Q1 2010
During the first quarter of the year sales have mainly consisted of deliveries of fingerprint readers to existing Match-on-Card customers, mainly in the government sector.
Related to marketing, a large number of trade events have also taken place in this quarter. For example, Precise Biometrics together with Sun Microsystems took part in the GSMA Mobile World Congress, the largest annual event in the mobile communication sector. Precise Biometrics demonstrated matching of fingerprints on SIM cards in mobile telephones in an application for ticketless travel. Together with Gemalto, Precise Biometrics also participated in the RSA Conference and HIMSS events in the US. The RSA Conference dominates the field in IT events, and HIMMS is the most important trade event for IT solutions in the healthcare sector. Gemalto demonstrated Gemalto.NET Bio, which is based on Precise Match-on-Card™ and the Windows Biometric Framework for Windows 7.
New business areas will be established in the new organization that comes into force on 1 July 2010. These will focus on solutions that can be marketed directly towards end-customers, as opposed to the present situation where sales are much more based on cooperation and integration with partners. The advantage of being able to address end-customers directly is that it is easier to influence the sales and decision-making processes. It also provides the opportunity to establish in-depth relations with a group of customers or market segments, and to develop and market streamlined solutions to solve tangible business problems. The process of working towards these new groups of customers was initiated in the first quarter of the year.
Parent company
Parent company sales for the first quarter amounted to SEK 17.2 million (10.3). Operating profit before tax for the first quarter amounted to SEK -0.4 million (1.1).
At the end of the first quarter 24 persons were employed in the parent company. Liquid assets at the end of the first quarter amounted to SEK 28.1 million (4.2). The parent company had no debts to credit institutions at the end of the first quarter. Investments in tangible fixed assets have been made to an amount of SEK 0.04 million (0.01)
During the first quarter costs for development work were capitalized to an amount of SEK 0.6 million (0.2).
PRECISE™ BIOMETRICS
Page 5 of 14
Lund, April 21, 2010
Organization and staff
The parent company of Precise Biometrics has its head office in Lund, Sweden. The organization also consists of the subsidiaries Precise Biometrics Inc. in Washington DC, USA, Precise Biometrics Solutions AB with office in Karlstad, Precise Biometrics Asia Ltd. with office in Hong Kong, as well as the dormant companies Precise Biometrics Services AB and Loqware Sweden AB (in the process of liquidation).
During 2010 Precise Biometrics will close the subsidiary Precise Biometrics Asia Ltd. We are still positive towards the developments in the Asian market, but our Asian marketing activities will be organized from the headquarters in Lund.
As of March 31, 2010 the group had 35 (41) employees, 33 in Sweden, 1 in the US and 1 in Hong Kong. Of these employees, 25 (32) were men and 10 (9) were women.
Investments in tangible fixed assets
In the first quarter the group has invested SEK 0.04 million (0.01) in tangible fixed assets.
Capitalization and depreciation of development work
During the first quarter costs for development work have been capitalized to an amount of SEK 0.6 million (0.3). Depreciation of capitalized costs for development work amounted in the first quarter to SEK 0.4 million (0.3).
Patents
The group's long-term patent strategy focuses on establishing a strong protection around Precise Match-on-Card™ as our core technology. The patents portfolio has been successively improved since 2001 and at the end of the first quarter in 2010 included 74 registered patents and 32 applications for patents in 21 different product families. Precise Biometrics has 13 different patent families just for the Match-on-Card technology.
Shares
The company's share is listed on the Small Cap list of the Nasdaq OMX Nordic.
The total number of registered shares at the end of the quarter was 134,960,800. During the quarter the average turnover per day was SEK 3,232 thousand and the list price ranged from SEK 2.58 to 1.94.
The main shareholders as of March 31, 2010
| Name | Percentage of share capital | No. of shares |
|---|---|---|
| Avanza Pension Försäkring | 6.3% | 8,507,594 |
| Swedbank Robur fonder | 3.9% | 5,315,932 |
| Stockpicker fonder | 3.0% | 4,061,468 |
| Nordnet Pensionsförsäkring | 2.0% | 2,724,003 |
Source: SIS Ågarservice
PRECISE™ BIOMETRICS
Page 6 of 14
Lund, April 21, 2010
Risk factors
Precise Biometrics is exposed to both commercial and financial risks, which to a large extent lie outside the reach and influence of the company. For a full account of identified risks, please refer to the Annual Report for 2009, that was submitted 1st of April 2010. No further essential risks or uncertainties have arisen after the submission of the Annual Report.
Future report dates
Interim Report Q2
July 20, 2010
Interim Report Q3
October 21, 2010
Year-end Report
February 4, 2011
Accounting principles
This interim report has been prepared in accordance with IAS 34, Interim reporting and the Swedish Company Accounts Act.
New IFRS, additions to IAS and IFRIC interpretations taking effect January 1, 2010, will not have a material effect on the financial statements.
For information on the applied accounting principles please refer to the Annual Report for 2009.
This quarterly report has not been subjected to review by the Company's auditors.
Lund, April 21, 2010
Thomas Marschall, President and CEO, Precise Biometrics AB (publ)
Page 7 of 14
Lund, April 21, 2010
Income statement, Group
| (Figures in thousands SEK) | Q1 | Q1 | Full year |
|---|---|---|---|
| 2010 | 2009 | 2009 | |
| Net sales | 19,280 | 12,196 | 68,655 |
| Cost of goods sold | -7,767 | -3,760 | -32,863 |
| Gross profit/loss | 11,513 | 8,436 | 35,792 |
| Selling expenses | -4,186 | -5,327 | -30,445 |
| Administrative expenses | -3,001 | -2,994 | -12,554 |
| R&D costs | -4,670 | -3,508 | -12,092 |
| Other operating income and changes in value | 112 | 990 | -977 |
| -11,745 | -10,839 | -56,068 | |
| Operating profit/loss | -232 | -2,403 | -20,276 |
| Financial costs | -98 | -178 | -1,492 |
| Profit/loss after financial items | -330 | -2,581 | -21,768 |
| Tax | - | - | -4 |
| Profit/loss for the period | -330 | -2,581 | -21,772 |
| Profit/loss attributable to: | |||
| Owners of the parent | -330 | -2,581 | -21,772 |
| Results per share, SEK | 0.00 | -0.03 | -0.19 |
Page 8 of 14
Lund, April 21, 2010
Comprehensive income, Group (according to IAS 1)
| (Figures in thousands SEK) | Q1 | Q1 | Full year |
|---|---|---|---|
| 2010 | 2009 | 2009 | |
| Change in accumulated exchange rate differences | 4 | -595 | 621 |
| Comprehensive income for the period, net of tax | 4 | -595 | 621 |
| Profit/loss for the period | -330 | -2,581 | -21,772 |
| Total comprehensive income for the period | -326 | -3,176 | -21,151 |
| Total comprehensive income attributable to: | |||
| Owners of the parent | -326 | -3,176 | -21,151 |
Balance Sheet, Group
| (Figures in thousands SEK) | 3/31/2010 | 3/31/2009 | 12/31/2009 |
|---|---|---|---|
| Assets | |||
| Intangible fixed assets | 4,087 | 9,370 | 3,802 |
| Tangible fixed assets | 805 | 1,197 | 868 |
| Inventories | 5,870 | 4,736 | 6,047 |
| Accounts receivable - trade | 11,982 | 7,237 | 16,758 |
| Other current receivables | 5,030 | 2,667 | 4,734 |
| Cash and bank balances | 35,497 | 4,448 | 40,884 |
| Total assets | 63,271 | 29,655 | 73,093 |
| Equity and liabilities | |||
| Equity | 45,082 | 12,751 | 45,408 |
| Current liabilities | 18,189 | 16,904 | 27,685 |
| Total equity and liabilities | 63,271 | 29,655 | 73,093 |
| Pledged assets | 23,400 | 17,400 | 26,400 |
| Contingent liabilities | - | - | - |
Page 9 of 14
Lund, April 21, 2010
Cash Flow Statement, Group
| (Figures in thousands SEK) | Q1 | Q1 | Full year |
|---|---|---|---|
| 2010 | 2009 | 2009 | |
| Cash flow from operating activities | |||
| before changes in working capital | -50 | -2,700 | -14,276 |
| Cash flow from changes in working capital | -4,649 | -3,840 | -6,931 |
| Cash flow from operating activities | -4,699 | -6,540 | -21,207 |
| Cash flow from investing activities | -688 | -278 | -1,299 |
| Cash flow from financing activities | - | -77 | 52,047 |
| Cash flow for the period | -5,387 | -6,895 | 29,541 |
| Liquid funds at the beginning of the period | 40,884 | 11,343 | 11,343 |
| Liquid funds at the end of the period | 35,497 | 4,448 | 40,884 |
Key Figures, Group
| 3/31/2010 | 3/31/2009 | 12/31/2009 | |
|---|---|---|---|
| Working capital (thousands SEK) | 40,190 | 2,184 | 40,738 |
| Liquid ratio | 289% | 85% | 225% |
| Equity/assets ratio | 71% | 43% | 62% |
| Return on average equity | - | - | neg |
| Capital employed (thousands SEK) | 46,400 | 12,751 | 46,900 |
| Return on capital employed | - | - | neg |
| Profit/loss per share (SEK) | 0.00 | -0.03 | -0.19 |
| EBITDA (thousands SEK) | 131 | -1,707 | -12,662 |
| Equity per share (SEK) | 0.33 | 0.13 | 0.34 |
| Number of shares | 134,960,800 | 101,220,600 | 134,960,800 |
| Number of employees at the end of the period | 35 | 41 | 36 |
| Average number of employees during the period | 35 | 43 | 38 |
Definitions - Key Figures
Working capital: Current assets less current liabilities
Liquid ratio: Current assets less inventories divided by current liabilities
Equity/assets ratio: Equity as of the balance sheet date divided by total assets as of the balance sheet date
Return on equity: Profit/loss for the period divided by average equity
Capital employed: Balance sheet total minus non-interest-bearing liabilities and provisions
Return on capital employed: Profit/loss after financial items plus financial expenses divided by the average capital employed
Profit/loss per share: Profit/loss after tax divided by the average number of shares. The options are not included in the calculation due to calculation of potential shares would result in an improvement in loss per share which is not permitted according to IAS 33
EBITDA: Profit/loss before net financial items, depreciations, write-downs and tax
Equity per share: Equity at the end of the period divided by the number of shares at the end of the period
Quarterly earnings ratios are not disclosed
Operating costs (as described on pg 4): Operating costs excluding costs for products sold, and excluding participations in associated companies, but including depreciation and write-downs and capitalization of costs for development work.
PRECISE™ BIOMETRICS
Page 10 of 14
Lund, April 21, 2010
Changes in equity, Group
(Figures in thousands SEK)
| Capital stock | Other paid in capital | Reserves | Balanced profit/ year's profit | Total equity | |
|---|---|---|---|---|---|
| Opening balance as at January 1, 2009 | 40,488 | 500,155 | -466 | -524,173 | 16,004 |
| Comprehensive income for the period | - | - | 621 | -21,772 | -21,151 |
| Transactions with the shareholders | |||||
| Stock option program¹) | - | -77 | - | - | -77 |
| New share issue²) | 13,496 | 37,136 | - | - | 50,632 |
| Closing balance as at December 31, 2009 | 53,984 | 537,214 | 155 | -545,945 | 45,408 |
| Comprehensive income for the period | - | - | 4 | -330 | -326 |
| Closing balance as at March 31, 2010 | 53,984 | 537,214 | 159 | -546,275 | 45,082 |
¹) Repurchase of 450,000 share options.
²) New share issue totalling 33 740 200 new shares at a rate of SEK 1.60 with deductions for issue costs SEK 3,352 thousand.
PRECISE™ BIOMETRICS
Page 11 of 14
Lund, April 21, 2010
Turnover and profitability by Regions Q1 2010
| (Figures in thousands SEK) | North America | Europe | Middle East & Africa | Asia | ||||
|---|---|---|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | |
| Net sales | 9,009 | 129 | 4,070 | 6,287 | 5,191 | 2,077 | 98 | 517 |
| Expenses¹⁾ | -5,126 | -579 | -2,097 | -4,234 | -3,481 | -1,161 | 51 | -796 |
| Operating profit/loss | 3,883 | -450 | 1,973 | 2,053 | 1,710 | 916 | 149 | -279 |
| Latin America | Other | Total | ||||||
| 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | |||
| Net sales | 912 | 3,186 | - | - | 19,280 | 12,196 | ||
| Expenses¹⁾ | - | - | - | - | -10,653 | -6,770 | ||
| Operating profit/loss | 912 | 3,186 | - | - | 8,627 | 5,426 |
¹⁾ The above expenses in Regions include Cost of goods sold as well as operation expenses for each region.
Page 12 of 14
Lund, April 21, 2010
Income statement, Parent company
| (Figures in thousands SEK) | |||
|---|---|---|---|
| Q1 2010 | Q1 2009 | Full Year 2009 | |
| Net sales | 17,176 | 10,281 | 57,397 |
| Cost of goods sold | -8,791 | -1,770 | -28,493 |
| Gross profit/loss | 8,385 | 8,511 | 28,904 |
| Selling expenses | -3,188 | -4,035 | -20,562 |
| Administrative expenses | -2,803 | -2,851 | -10,390 |
| R&D costs | -3,158 | -3,992 | -12,092 |
| Other operating income and changes in value | 312 | 3,556 | -3,174 |
| -8,837 | -7,322 | -46,218 | |
| Operating profit/loss | -452 | 1,189 | -17,314 |
| Financial costs^{1)} | 30 | -56 | -6,507 |
| Profit/loss after financial items | -422 | 1,133 | -23,821 |
| Tax | - | - | - |
| Profit/loss for the period | -422 | 1,133 | -23,821 |
1) Include a write-down of the value in the subsidiary Precise Biometrics Solutions AB amounting SEK 5.5 million in 2009
Page 13 of 14
Lund, April 21, 2010
Balance Sheet, Parent company
(Figures in thousands SEK)
| 3/31/2010 | 3/31/2009 | 12/31/2009 | |
|---|---|---|---|
| Assets | |||
| Intangible fixed assets | 3,947 | 4,383 | 3,655 |
| Tangible fixed assets | 437 | 741 | 479 |
| Participations in group companies | 1,058 | 6,540 | 1,058 |
| Inventories | 5,870 | 4,736 | 6,047 |
| Accounts receivable - trade | 4,862 | 6,040 | 6,176 |
| Other current receivables | 46,853 | 44,452 | 54,865 |
| Cash and bank balances | 28,080 | 4,161 | 28,494 |
| Total assets | 91,107 | 71,053 | 100,774 |
| Equity and liabilities | |||
| Equity | 79,341 | 58,861 | 79,763 |
| Other provisions | 225 | 638 | 284 |
| Current liabilities | 11,541 | 11,554 | 20,727 |
| Total equity and liabilities | 91,107 | 71,053 | 100,774 |
| Pledged assets | 21,000 | 15,000 | 24,000 |
| Contingent liabilities | 2,000 | 2,000 | 2,000 |
PRECISE™ BIOMETRICS
Page 14 of 14
Lund, April 21, 2010
Telephone conference
On the occasion of today's Interim Report we have the pleasure to invite investors and journalists to the following informative meeting during the day
- The conference starts at 14:30 (CET)
- To participate, please call +46 (0)8 506 269 04
An operator will note your name and connect you to the conference. She/he will also provide you with information about what to do if you have any questions.
The presentation will be held in English but afterwards there will be an opportunity to ask questions in Swedish.
Participating on behalf of Precise Biometrics
- Thomas Marschall, President and CEO
- Patrik Norberg, CFO
A recording from the conference will be available for three days after the telephone meeting. To listen to the conference afterwards dial +46 (0)8 506 269 49. When asked to state a reference number please dial 242399 and finish with (#).
Please visit www.precisebiometrics.com/presentations where a presentation can be downloaded.
For further information
Thomas Marschall, President and CEO, Precise Biometrics
Tel. +46 (0)46 31 11 10 or +46 (0)734 35 11 10
E-mail [email protected]
Patrik Norberg, CFO, Precise Biometrics AB
Tel. +46 46 31 11 47 or +46 734 35 11 47
E-mail [email protected]
Precise Biometrics AB (Headquarters)
Box 798
SE-220 07 Lund
Tel.: +46 (0)46 31 11 00
Fax: +46 (0)46 31 11 01
E-mail: [email protected]
Precise Biometrics is a market-leading provider of products and solutions for fingerprint recognition. The technology proves people's identities in a fast and secure way, while it reduces costs related to password management, identity theft and fraud.
Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 100 million users. Precise Biometrics is listed on NASDAQ OMX Stockholm small cap list (PREC). For more information, please visit www.precisebiometrics.com.